WHO ICTRP trial
The benefit of minocycline on negative symptoms in schizophrenia
ISRCTN49141214 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN49141214 |
|---|---|
| Public title | The benefit of minocycline on negative symptoms in schizophrenia |
| Scientific title | The benefit of minocycline on negative symptoms in schizophrenia: Extent and mechanisms |
| Primary sponsor | Manchester Mental Health And Social Care NHS Trust |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom;England;Scotland |
| Conditions | Specialty: Mental Health, Primary sub-specialty: Psychosis Mental and Behavioural Disorders |
| Interventions | Participants are randomised to one of two groups according to a randomised permuted blocks algorithm, after stratification by centre, as specified by the trial statistician. Intervention group: Participants take 300mg daily minocycline for… |
| Registration date | Dec 12, 2016 |
| Target size | 170 |
| Secondary IDs | 2010-022463-35;10411 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: